Medicine Supply Notification: Fluticasone 50microgram / Salmeterol 25microgam (Combisal® ) pressurised metered dose inhaler (pMDI)
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fluticasone 50microgram / Salmeterol 25microgam (Combisal®) pressurised metered dose inhaler (pMDI).
MSN/2022/108
Tier 2 – medium impact
Date of issue 21st December 2022
- Fluticasone 50microgram / salmeterol 25microgram (Combisal®) pressurised metered dose inhaler (pMDI) is out of stock until early January 2023.
- Alternate brands of fluticasone 50microgram with salmeterol 25microgram inhalers (pMDI) remain available and can support a full uplift in demand.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
